Target intelligence / Profile preview

Type 1 fimbriae and P pili (T1F (Type 1 fimbriae); Pap (P pili))

Target
T1F (Type 1 fimbriae); Pap (P pili)
Molecular classification
Chaperone-usher fimbriae, Adhesin, Pilus
01

Overview

Type 1 fimbriae and P pili are prototypical chaperone-usher pathway (CUP) fimbrial structures on uropathogenic Escherichia coli (UPEC), enabling adhesion to host urinary tract tissues and promoting infection. Type 1 fimbriae (T1F), encoded by the fim operon (fimAICDFGH), form a 1-2 μm hair-like pilus with a helical rod of ~1000 FimA major subunits tipped by adaptor proteins (FimF, FimG) and the FimH adhesin, which binds mannosylated glycoproteins on bladder urothelium. P pili, encoded by the pap operon (papIBAHCDJKEFG), feature a similar structure with PapA rod subunits, PapH termination, and PapG adhesin targeting Gal(α1-4)Gal moieties in the kidney. Both undergo phase-variable expression regulated by invertible DNA switches (fimS for T1F), recombinases (FimB/E), and global factors like H-NS, Lrp, and PapB/PapI, responding to environmental cues. In disease, coordinated T1F (bladder) and P pilus (kidney) expression drives UPEC colonization, invasion, intracellular communities, and biofilms, evading clearance during urination via rod uncoiling as a molecular spring. No approved drugs directly target these structures, but their essential role in UTI pathogenesis positions them as validated antibacterial targets.

Other names
Type 1 fimbria (T1F, Fim)P fimbriae (P pilus, Pap pili)
02

Biological functions

Bacterial adhesion to host cellsColonization of urinary tract epitheliumFormation of intracellular bacterial communities and biofilmsHost-pathogen interactionPhase-variable expression
03

Disease associations

Urinary tract infection (UTI)Uropathogenic Escherichia coli (UPEC) pathogenesisCystitisPyelonephritis

Beyond the preview

Go deeper on Type 1 fimbriae and P pili (T1F (Type 1 fimbriae); Pap (P pili)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type 1 fimbriae and P pili (T1F (Type 1 fimbriae); Pap (P pili)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call